EUVIMEDEUVIMED entdecken
Historischer BeitragOpen Access · CC BY 4.0

A journey through the history of PEGylated drug delivery nanocarriers

Ana M López-Estevez, Ruxandra Gref, Maria J Alonso

Drug Delivery and Translational Research · 2024-08 · 14 (8) · 2026-2031

DOI: 10.1007/s13346-024-01608-8 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 25.05.2024. Verfasst von Ana M López-Estevez und 2 weiteren Autor:innen. Beteiligte Einrichtung: CIMUS Research Institute and IDIS Research Institute, Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Drug Carriers, Nanoparticles, Polyethylene Glycols. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade de Santiago de Compostela.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This note aims to inspire through providing a personal view of the development and potential Drug Delivery Nanocarriers functionalized with polythyleneglycol (PEG). This polymer has been used extensively in Pharmaceutical Technology in a variety of compositions, including polyethylene oxide (PEO)-based surfactants. However, the concept of PEGylation, which started in the 70’s, differs from the functionality of a surfactant, already discloses in the 50’s. Here, we strictly adhere to the biological functionality of PEGylated nanocarriers intended to have a reduced interaction with proteins and, therefore, modify their biodistribution as well as facilitate their diffusion across mucus and other biological barriers. We analyze how this concept has evolved over the years and the benefit obtained so far in terms of marketed nanomedicines and provide the readers with a prospect view of the topic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CarriersNanoparticlesPolyethylene GlycolsAnimalsHumansDrug Delivery Systems

Stichwörter der Autor:innen

Drug targetingNanoparticlesPEGylation

Substanzen

Drug CarriersPolyethylene Glycols

Autor:innen und Institutionen

  • CIMUS Research Institute and IDIS Research Institute, Santiago de Compostela, Spain.
  • Department of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Institut of Molecular Sciences, Université Paris-Saclay, CNRS, ISMO UMR 8216, Orsay, France.
  • CIMUS Research Institute and IDIS Research Institute, Santiago de Compostela, Spain. mariaj.alonso@usc.es.
  • Department of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain. mariaj.alonso@usc.es.

Förderung

  • Universidade de Santiago de Compostela

Zitieren

APA

López-Estevez, A. M., Gref, R., & Alonso, M. J. (2024). A journey through the history of PEGylated drug delivery nanocarriers. Drug Delivery and Translational Research, 14(8), 2026-2031. https://doi.org/10.1007/s13346-024-01608-8

Vancouver

López-Estevez AM, Gref R, Alonso MJ. A journey through the history of PEGylated drug delivery nanocarriers. Drug Delivery and Translational Research. 2024;14(8):2026-2031. doi:10.1007/s13346-024-01608-8

BibTeX
@article{LpezEstevez2024,
  author = {López-Estevez, Ana M and Gref, Ruxandra and Alonso, Maria J},
  title = {A journey through the history of PEGylated drug delivery nanocarriers},
  journal = {Drug Delivery and Translational Research},
  year = {2024},
  volume = {14},
  number = {8},
  pages = {2026--2031},
  doi = {10.1007/s13346-024-01608-8}
}
Kostenlos starten →